Literature DB >> 9805179

Primary vasculitis in a Norwegian community hospital: a retrospective study.

G Haugeberg1, R Bie, A Bendvold, A S Larsen, V Johnsen.   

Abstract

Primary systemic vasculitic diseases are relatively rare. Untreated, they have a high morbidity and mortality. The introduction of steroids and cytotoxic drugs has dramatically reduced the mortality. In a retrospective study in a Norwegian community hospital, which serves a county with a population of 150,426 in 1996, 68 patients were found to have a primary vasculitis, 63 of whom fulfilled the ACR 1990 criteria. Patients with Henoch-Schönlein purpura aged less than 16 years and patients with Kawasaki's disease were excluded. The overall prevalence was 43.9 per 100,000 inhabitants (Churg-Strauss syndrome 1.3, hypersensitivity vasculitis 2.7, Henoch-Schönlein purpura 3.3, polyarteritis nodosa 3.3, Wegener's granulomatosis 5.3 and temporal arteritis 27.9). In most cases, disease control was achieved with corticosteroids alone, or with the addition of cytotoxic drugs. Two patients had died in the latest 5-year period but of unrelated disorders. Biopsy plays a major role in diagnosing vasculitic diseases. In our study, 62 patients had a positive biopsy supporting the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805179     DOI: 10.1007/bf01450893

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  The effect of cortisone on the lesions of periarteritis nodosa.

Authors:  A H BAGGENSTOSS; R M SHICK; H F POLLEY
Journal:  Am J Pathol       Date:  1951 Jul-Aug       Impact factor: 4.307

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

Review 3.  Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes.

Authors:  J T Lie
Journal:  Rheum Dis Clin North Am       Date:  1990-05       Impact factor: 2.670

4.  Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.

Authors:  J W Tervaert; P C Limburg; J D Elema; M G Huitema; G Horst; T H The; C G Kallenberg
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

Review 5.  When is arteritis of the temporal arteries not temporal arteritis?

Authors:  J T Lie
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

Review 6.  Histopathologic specificity of systemic vasculitis.

Authors:  J T Lie
Journal:  Rheum Dis Clin North Am       Date:  1995-11       Impact factor: 2.670

Review 7.  Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

Authors:  C G Kallenberg; E Brouwer; J J Weening; J W Tervaert
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

Review 8.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

Review 9.  Classification of vasculitis.

Authors:  B A Michel
Journal:  Curr Opin Rheumatol       Date:  1992-02       Impact factor: 5.006

10.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1990-08
View more
  15 in total

1.  Systemic vasculitis: epidemiology, classification and environmental factors.

Authors:  D G Scott; R A Watts
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 2.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

Review 3.  The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries.

Authors:  Sophia Lionaki; John N Boletis
Journal:  Kidney Dis (Basel)       Date:  2015-12-05

4.  Increased serum high mobility group box-1 level in Churg-Strauss syndrome.

Authors:  T Taira; W Matsuyama; H Mitsuyama; K-I Kawahara; I Higashimoto; I Maruyama; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

5.  Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.

Authors:  G Haugeberg; B Griffiths; K B Sokoll; P Emery
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

6.  A case of isolated renal involvement of polyarteritis nodosa successfully treated with steroid monotherapy.

Authors:  Negiin Pourafshar; Eric Sobel; Mark Segal
Journal:  BMJ Case Rep       Date:  2016-07-20

7.  Stable incidence of systemic vasculitides in schleswig-holstein, Germany.

Authors:  Karen Herlyn; Bernhard Hellmich; Wolfgang L Gross; Eva Reinhold-Keller
Journal:  Dtsch Arztebl Int       Date:  2008-05-09       Impact factor: 5.594

8.  The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.

Authors:  Ömer Nuri Pamuk; Salim Dönmez; Gökçe Büşra Calayır; Gülsüm Emel Pamuk
Journal:  Clin Rheumatol       Date:  2016-03-18       Impact factor: 2.980

Review 9.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

10.  Bilateral renal hemorrhage due to polyarteritis nodosa wrongly attributed to blunt trauma.

Authors:  Ihab El Madhoun; Niall G Warnock; Anu Roy; Colin H Jones
Journal:  Nat Rev Urol       Date:  2009-10       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.